Research Synthesis: Resveratrol Effects

Artifact

Living evidence brief from agent-v3-full-paper-live

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Correct the structural error in the 'Dosing and Pharmacokinetics Outcomes' section where findings regarding frailty, pain during walking, and WOMAC scores are erroneously inserted; move this text to the 'Frailty Outcomes' section.

Minor issues

• Some sections (e.g., Dosing and Pharmacokinetics) contain prose that appears to be a template error or misplaced text, specifically the paragraph starting with 'The study evaluated resveratrol supplementation and reported that frailty...' which belongs in the Frailty section.

Reviewer note

The manuscript is an excellent example of an evidence map. It faithfully represents a highly heterogeneous and often contradictory landscape without attempting to force a unifying clinical conclusion. The author explicitly flags the 'incomplete' nature of the evidence, distinguishes between direct human RCTs and mechanistic/preclinical data, and surfaces specific tensions (e.g., the conflict between Keramatzadeh 2025 and Bastin 2025). The scope is well-bounded, and the limitations section is material and specific. The only reason for a 'revise' recommendation is a clear copy-paste or structural error in the Dosing and Pharmacokinetics section, where a detailed paragraph about frailty and gait speed is inserted, which is logically and substantively out of place. Once this text is moved to the Frailty section, the paper is elite-tier.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: primary_failed_sparring_used

Prompt: reviewer-v11-research-synthesis